Solvay SA (SOLB)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 23.24 |
|---|---|
| 52-week range | 22.58 – 29.16 |
| Return, 1 month / 3 months | −8.8% / −12.3% |
| Return, 1 year / 3 years | −9.2% / +57.8% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -16.4% |
| Average daily value traded | 8.77M EUR |
| Dividend yield | 10.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Solvay is a Belgian chemicals group that makes advanced materials and specialty chemical products. Its range includes soda ash, hydrogen peroxide, silica, rare earths and specialty polymers, which are supplied to customers in industries such as automotive, aerospace, electronics, construction and consumer goods. The company is based in Brussels and operates industrial sites and research facilities across several continents, serving manufacturers and industrial buyers rather than household consumers directly.
The shares are listed on the Euronext Brussels in Belgium under the code SOLB, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Solvay SA (SOLB) trades on the Euronext Brussels in Belgium. It last closed at EUR 23.24 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 47 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.2% and over the last three months it fell 12.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.3% | ||
| From 52-week high | -19.5% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.3% | ||
| 6-month return | -11.0% | ||
| 12-month return, skipping the last month | -0.5% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.4% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 8.77M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.7% |
|---|---|
| 1 month | −8.8% |
| 3 months | −12.3% |
| 6 months | −11.0% |
| 1 year | −9.2% |
| 3 years | +57.8% |
| 5 years | +119.7% |
Signals
| 50-day / 200-day average | 25.23 / 25.62 |
|---|---|
| Golden / death cross (60 days) | Death, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 1.4600 |
| 19 Jan 2026 | EUR 0.9700 |
| 19 May 2025 | EUR 1.4600 |
| 20 Jan 2025 | EUR 0.9700 |
| 3 Jun 2024 | EUR 0.8100 |
| 15 Jan 2024 | EUR 1.6200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.